Liana K Billings Selected Research

Type 2 Diabetes Mellitus (MODY)

10/2023	Precision subclassification of type 2 diabetes: a systematic review.
10/2023	The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
5/2023	Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study.
4/2023	Systematic review of precision subclassification of type 2 diabetes.
1/2023	Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
1/2023	Effect of a Type 2 Diabetes-Focused Visit Improvement Initiative on Therapeutic Inertia and Glycemic Control in Primary Care.
1/2022	Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes.
12/2021	Leveraging advances in diabetes technologies in primary care: a narrative review.
11/2021	Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
1/2021	The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liana K Billings Research Topics

Disease

26	Type 2 Diabetes Mellitus (MODY) 10/2023 - 11/2010
7	Hypoglycemia (Reactive Hypoglycemia) 05/2023 - 01/2015
7	Body Weight (Weight, Body) 01/2022 - 01/2018
5	Weight Loss (Weight Reduction) 01/2021 - 01/2018
4	Obesity 05/2024 - 03/2013
3	Weight Gain 01/2021 - 01/2018
3	Insulin Resistance 03/2014 - 03/2013
1	Lipodystrophy 05/2024
1	Chronic Renal Insufficiency 10/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021
1	Diabetes Complications 12/2021
1	Infections 06/2021
1	COVID-19 06/2021
1	Sickle Cell Trait 06/2021
1	Overweight 01/2021
1	Body Weight Changes 01/2021
1	Nausea 01/2019
1	Hyperglycemia 09/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2018
1	Stroke (Strokes) 09/2018
1	Hypertension (High Blood Pressure) 09/2014

Drug/Important Bio-Agent (IBA)

12	Insulin (Novolin)FDA Link 05/2023 - 08/2012
8	Insulin Glargine (Lantus)FDA Link 05/2023 - 01/2018
8	IDegLiraIBA 01/2023 - 01/2018
8	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 08/2012
7	insulin degludecIBA 05/2023 - 04/2018
6	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 12/2013
6	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2018
5	Liraglutide FDA Link 01/2023 - 04/2018
2	semaglutideIBA 01/2021 - 09/2018
2	Glipizide (Glucotrol)FDA LinkGeneric 01/2015 - 12/2013
2	hydroxide ionIBA 09/2014 - 03/2013
2	25-hydroxyvitamin DIBA 09/2014 - 03/2013
2	Vitamin D FDA LinkGeneric 09/2014 - 03/2013
1	LipidsIBA 05/2024
1	ProinsulinIBA 05/2024
1	finerenoneIBA 10/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 06/2021
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	SodiumIBA 01/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 09/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2018
1	omega-Chloroacetophenone (Mace)IBA 09/2018
1	lixisenatideIBA 04/2018
1	DiamondIBA 01/2018
1	Insulin Aspart (NovoLog)FDA Link 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	SugarsIBA 01/2015
1	zinc-binding protein (zinc binding protein)IBA 05/2014
1	Triglycerides (Triacylglycerol)IBA 03/2014
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 12/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 12/2013
3	Glycemic Control 01/2023 - 09/2018
2	Precision Medicine 10/2023 - 04/2023
2	Drug Therapy (Chemotherapy) 01/2021 - 11/2010
2	Injections 12/2019 - 01/2018
1	Ambulatory Care (Outpatient Care) 01/2023
1	Caloric Restriction 01/2021